Three new Cochrane reviews report that GLP-1 drugs can lead to meaningful weight loss, although the strong involvement of pharmaceutical companies in many studies raises concerns. The World Health Organization...

Researchers at Tokyo Metropolitan University have turned to concepts from polymer physics to better understand a central feature of Alzheimer's disease: the formation of tau protein fibrils. Their work revealed...

A new study from the University of California San Diego suggests that glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications originally developed for type 2 diabetes, may have benefits...

The dollar isn’t what it used to be—that’s especially true at the grocery store. We have seen significant increases in global food prices in recent years. In 2023, there was...

Heart disease remains the world's top killer, claiming more lives each year than any other condition. Scientists are uncovering how gut microbes may influence coronary artery disease (CAD), one of...

If you’re taking a GLP-1, you’re probably familiar with two big shifts: you feel full sooner and digestion may slow. (1) This may make a typical breakfast hard to finish—or...

Serious injury to short-term kidney function, known as acute kidney injury (AKI), can be life-threatening and also raise the likelihood of developing permanent chronic kidney disease. AKI can occur after...

If you go to an emergency room, you’ll be seen even if you don’t have insurance. But depending on your situation, it may not be the right place to start...

Gout is one of the oldest documented human illnesses. It develops when sharp crystals form inside joints, triggering intense swelling and pain, and is considered a type of arthritis. Researchers...

Whether it’s checking your cholesterol, screening for diabetes or monitoring a chronic condition, lab work is a routine part of health care. These tests analyze samples of blood, urine or...